Enhancing antiepileptic drug adherence: A randomized controlled trial

Epilepsy and Behavior

Volumn 16, Issue 4, 2009, Pages 634-639

  Brown, Ian ^a   Sheeran, Paschal ^a   Reuber, Markus ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Adherence; Antiepileptic drugs; Compliance; Epilepsy; Implementation intentions; Randomized controlled trial

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; ZONISAMIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SELF REPORT;

ADULT; ANALYSIS OF VARIANCE; ANTICONVULSANTS; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SELECTION; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 70449518015     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.09.014     Document Type: Article

References (40)

1. Kwan P., and Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 342 (2000) 314-319
2. Schuele S.U., and Luders H.O. Intractable epilepsy: management and therapeutic alternatives. Lancet Neurol 7 (2008) 514-524
3. Leppik I.E. How to get patients with epilepsy to take their medication: the problem of noncompliance. Postgrad Med 88 (1990) 253-256
4. DiMatteo M.R. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42 (2004) 200-209
5. Chen J.W.Y., and Wasterlain C.G. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 5 (2006) 246-256
6. Buelow J.M., and Smith M.C. Medication management by the person with epilepsy: perception versus reality. Epilepsy Behav 5 (2004) 401-406
7. Cramer J.A., Glassman M., and Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 3 (2002) 338-342
8. Williams J., Myson V., Steward S., et al. Self-discontinuation of antiepileptic medication in pregnancy: detection by hair analysis. Epilepsia 43 (2002) 824-831
9. Buck D., Jacoby A., Baker G.A., and Chadwick D.W. Factors influencing compliance with antiepileptic drug regimes. Seizure 6 (1997) 87-93
10. Thatcher Shope J. Compliance in children and adults: review of studies. Epilepsy Res Suppl 1 (1988) 23-47
11. Faught E., Duh M.S., Weiner J.R., Guerin A., and Cunnington M.C. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology 71 (2008) 1572-1578
12. Cramer J.A., Mattson R.H., Prevey M.L., Scheyer R.D., and Ouellette V.L. How often is medication taken as prescribed? A novel assessment technique. JAMA 261 (1989) 3273-3277
13. Davis K.L., Candrilli S.D., and Edin H.M. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia 49 (2008) 446-454
14. Peterson G.M., McLean S., and Millingen K.S. A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia 25 (1984) 412-417
15. Takaki S., Kurokawa T., and Aoyama T. Monitoring drug noncompliance in epileptic patients: assessing phenobarbital plasma levels. Ther Drug Monit 7 (1985) 87-91
16. Stanaway L., Lambie D.G., and Johnson R.H. Non-compliance with anticonvulsant therapy as a cause of seizures. N Z Med J 98 (1985) 150-152
17. Irving P., Al D.A., Srinivasan A., and Greenwood R. An audit of admissions of patients with epilepsy to a district general hospital. Seizure 8 (1999) 166-169
18. Williams J., Lawthom C., Dunstan F.D., et al. Variability of antiepileptic medication taking behaviour in sudden unexplained death in epilepsy: hair analysis at autopsy. J Neurol Neurosurg Psychiatry 77 (2006) 481-484
19. Sherwin A.L., Robb J.P., and Lechter M. Improved control of epilepsy by monitoring plasma ethosuximide. Arch Neurol 28 (1973) 178-181
20. Wannamaker B.B., Morton Jr. W.A., Gross A.J., and Saunders S. Improvement in antiepileptic drug levels following reduction of intervals between clinic visits. Epilepsia 21 (1980) 155-162
21. Gollwitzer P.M., and Sheeran P. Implementation intentions and goal achievement: a meta-analysis of effects and processes. Adv Exp Soc Psychol 38 (2006) 119
22. Gollwitzer P.M. Implementation intentions: strong effects of simple plans. Am Psychol 54 (1999) 493-503
23. Webb T.L., and Sheeran P. How do implementation intentions promote goal attainment? A test of component processes. J Exp Soc Psychol 43 (2007) 295-302
24. Broadbent E., Petrie K.J., Main J., and Weinman J. The brief illness perception questionnaire. J Psychosom Res 60 (2006) 631-637
25. Seidenberg M., Haltiner A., Taylor M.A., Hermann B.B., and Wyler A. Development and validation of a Multiple Ability Self-report Questionnaire. J Clin Exp Neuropsychol 16 (1994) 93-104
26. Zigmont A.S., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
27. Scott-Lennox J., Bryant-Comstock L., Lennox R., and Baker G.A. Reliability, validity and responsiveness of a revised scoring system for the Liverpool Seizure Severity Scale. Epilepsy Res 44 (2001) 53-63
28. Baker G.A., Smith D.F., Jacoby A., Hayes J.A., and Chadwick D.W. Liverpool Seizure Severity Scale revisited. Seizure 7 (1998) 201-205
29. Crawford J.R., Smith G., Maylor E.A., Della S.S., and Logie R.H. The Prospective and Retrospective Memory Questionnaire (PRMQ): normative data and latent structure in a large non-clinical sample. Memory 11 (2003) 261-275
30. Aiken L.S., and West S.G. Multiple regression: testing and interpreting interactions (1991), Sage, Newbury Park, CA
31. McDonald H.P., Garg A.X., and Haynes R.B. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 288 (2002) 2868-2879
32. Jones R.M., Butler J.A., Thomas V.A., Peveler R.C., and Prevett M. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 15 (2006) 504-508
33. Lengfelder A., and Gollwitzer P.M. Reflective and reflexive action control in patients with frontal brain lesions. Neuropsychology 15 (2001) 80-100
34. Sheeran P., Aubrey R., and Kellet S. Increasing attendance for psychotherapy: implementation intentions and the self-regulation of attendance-related negative affect. J Consult Clin Psychol 75 (2007) 853-863
35. Sheeran P., Milne S., Webb T.L., and Gollwitzer P.M. Implementation intentions and health behaviours. In: Conner M., and Norman P. (Eds). Predicting health behaviour: research and practice with social cognition models. 2nd ed. (2005), Open Univ. Press, Buckingham 276-323
36. Mattson R.H., Cramer J.A., and Collins J.F. Aspects of compliance: taking drugs and keeping clinic appointments. Epilepsy Res Suppl 1 (1988) 111-117
37. Leppik I.E. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population. Epilepsy Res Suppl 1 (1988) 85-90
38. Dunbar-Jacob J., and Mortimer-Stephens M.K. Treatment adherence in chronic disease. J Clin Epidemiol 54 Suppl. 1 (2001) S57-S60
39. Cramer J., Vachon L., Desforges C., and Sussman N.M. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 36 (1995) 1111-1117
40. Williams J., Patsalos P.N., Mei Z., Schapel G., Wilson J.F., and Richens A. Relation between dosage of carbamazepine and concentration in hair and plasma samples from a compliant inpatient epileptic population. Ther Drug Monit 23 (2001) 15-20